Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Mar;43(3):1085–1087. doi: 10.1128/iai.43.3.1085-1087.1984

Activation of human complement by the pneumococcal toxin pneumolysin.

J C Paton, B Rowan-Kelly, A Ferrante
PMCID: PMC264298  PMID: 6698602

Abstract

Highly purified pneumolysin (at a concentration of 10 micrograms/ml) caused significant activation of human complement, as measured by conversion of C3. Complement activation in the presence of pneumolysin was not observed in sera chelated with a combination of Mg2+ and ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid, and activation was only slight in C2-deficient sera. This suggests that the toxin is capable of activating the classical complement pathway. Treatment of normal human serum with pneumolysin also significantly reduced its opsonic activity for Streptococcus pneumoniae.

Full text

PDF
1085

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  2. Coonrod J. D., Jenkins S. Interaction of pneumococcal antigens with complement in rats. Infect Immun. 1979 Mar;23(3):626–632. doi: 10.1128/iai.23.3.626-632.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coonrod J. D., Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect Immun. 1977 Oct;18(1):14–22. doi: 10.1128/iai.18.1.14-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coonrod J. D., Yoneda K. Comparative role of complement in pneumococcal and staphylococcal pneumonia. Infect Immun. 1982 Sep;37(3):1270–1277. doi: 10.1128/iai.37.3.1270-1277.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gemmell C. G., Peterson P. K., Townsend K., Quie P. G., Kim Y. Biological effects of the interaction of staphylococcal alpha-toxin with human serum. Infect Immun. 1982 Dec;38(3):981–985. doi: 10.1128/iai.38.3.981-985.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hosea S. W., Brown E. J., Frank M. M. The critical role of complement in experimental pneumococcal sepsis. J Infect Dis. 1980 Dec;142(6):903–909. doi: 10.1093/infdis/142.6.903. [DOI] [PubMed] [Google Scholar]
  7. Johnson M. K., Boese-Marrazzo D., Pierce W. A., Jr Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect Immun. 1981 Oct;34(1):171–176. doi: 10.1128/iai.34.1.171-176.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Matthay K. K., Mentzer W. C., Wara D. W., Preisler H. K., Lameris N. B., Ammann A. J. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun. 1981 Jan;31(1):228–235. doi: 10.1128/iai.31.1.228-235.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Paton J. C., Ferrante A. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun. 1983 Sep;41(3):1212–1216. doi: 10.1128/iai.41.3.1212-1216.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Paton J. C., Lock R. A., Hansman D. J. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun. 1983 May;40(2):548–552. doi: 10.1128/iai.40.2.548-552.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Prellner K. Complement activation by pneumococci associated with acute otitis media. Acta Pathol Microbiol Scand C. 1979 Jun;87C(3):213–216. [PubMed] [Google Scholar]
  12. Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stimler N. P., Hugli T. E., Bloor C. M. Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol. 1980 Aug;100(2):327–348. [PMC free article] [PubMed] [Google Scholar]
  14. Thong Y. H., Simpson D. A., Müller-Eberhard H. J. Homozygous deficiency of the second component of complement presenting with recurrent bacterial meningitis. Arch Dis Child. 1980 Jun;55(6):471–473. doi: 10.1136/adc.55.6.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Winkelstein J. A. The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis. 1981 Mar-Apr;3(2):289–298. doi: 10.1093/clinids/3.2.289. [DOI] [PubMed] [Google Scholar]
  16. Winkelstein J. A., Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol. 1978 Jan;120(1):174–178. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES